DIA-G COMBINATION PRODUCT CAPSULE

Indications

• Digestive disorders
• Diarrhea
• Constipation
• Respiratory infections
• Inflammatory conditions
• Metabolic disorders

Dosage

Children: Refer to established pharmacological guidelines and clinical literature for specific dosing recommendations, which may vary based on the preparation used.

Adults: Refer to established pharmacological guidelines and clinical literature for specific dosing recommendations, which may vary based on the preparation used.

Mechanism of action

The active compounds in Aegle marmelos, such as flavonoids and alkaloids, exert their effects through multiple pathways, including the modulation of oxidative stress and inflammation. These compounds may inhibit various enzymes involved in the inflammatory pathways, enhance antioxidant defense systems, and promote gut health by modulating gut microbiota.

Pharmacodynamics

Aegle exhibits a range of pharmacological activities. It has demonstrated efficacy in reducing oxidative stress through the scavenging of free radicals. The anti-inflammatory properties are attributed to the inhibition of pro-inflammatory cytokines and enzymes, potentially benefiting conditions like arthritis and inflammatory bowel disease. Additionally, its antimicrobial effects contribute to its use in treating gastrointestinal infections and other infections.

Pharmacokinetics

The pharmacokinetics of Aegle marmelos are not well-characterized in clinical studies. However, the bioactive compounds are generally absorbed in the gastrointestinal tract, with distribution being influenced by their solubility and lipophilicity. Metabolism may occur in the liver, and excretion is likely through renal pathways. The onset of action can vary depending on the formulation and method of administration.

Pregnancy

There is limited information on the safety of Aegle during pregnancy. It is advisable to avoid use unless absolutely necessary and prescribed by a healthcare provider.

Breast-feeding

Due to insufficient data on the excretion of Aegle in breast milk, caution is advised when administering to breastfeeding mothers.

Storage

Store in a cool, dry place away from direct sunlight, and keep out of reach of children.

Indications

• Inflammatory conditions
• Cancer prevention and treatment
• Antioxidant therapy
• Digestive disorders
• Cardiovascular health

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing guidelines, as dosages can vary based on the formulation and clinical indication.

Mechanism of action

Curcumin acts as a scavenger of reactive oxygen species, including hydroxyl radicals and superoxide anions, and inhibits lipid peroxidation as well as peroxide-induced DNA damage. It exhibits potent anti-inflammatory and anti-carcinogenic effects by modulating various signaling molecules. Curcumin inhibits protein kinases, c-Jun/AP-1 activation, and cyclooxygenase (COX)-2 activity, impacting cellular signal transduction pathways related to growth and malignant transformation.

Pharmacodynamics

In experimental animal models, curcumin has demonstrated significant pharmacological effects, such as increasing bile flow and inhibiting inflammation and edema formation. It has been shown to decrease cell proliferation and promote apoptosis in cancer cells. Additionally, curcumin inhibits platelet aggregation induced by arachidonic acid, suggesting its role in cardiovascular health.

Pharmacokinetics

Curcumin's pharmacokinetics are characterized by low bioavailability due to rapid metabolism and systemic elimination. It undergoes extensive hepatic metabolism, leading to the production of several metabolites. The absorption of curcumin can be enhanced by co-administration with piperine. Oral bioavailability remains a challenge, which has led to the exploration of various formulations to improve its therapeutic efficacy.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Diarrhea
• Allergic reactions

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications
• May interfere with the metabolism of certain drugs due to inhibition of cytochrome P450 enzymes

Precautions

• Use with caution in patients with gallbladder disease
• Monitor patients on anticoagulant therapy
• Caution in patients with diabetes due to potential hypoglycemic effects

Pregnancy

Safety during pregnancy has not been established, caution is advised.

Breast-feeding

Curcumin may be excreted in breast milk, caution is advised.

Storage

Store in a cool, dry place away from light.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extracts

Indications

• Antioxidant support
• Enhancement of immune function
• Skin health improvement
• Digestive health support
• Metabolic syndrome management
• Hepatoprotective therapy

Dosage

Children: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established herbal guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The active compounds in emblica, particularly emblicanin A and B, have been shown to exhibit antioxidant activity by scavenging free radicals and reducing oxidative stress. This action helps protect cells from damage, particularly in the liver and other organs. Additionally, emblica may modulate various biochemical pathways, including the enhancement of glutathione levels, which is critical for detoxification and cellular protection.

Pharmacodynamics

Emblica demonstrates a range of pharmacological effects, including anti-inflammatory, antimicrobial, and hepatoprotective actions. The fruit has been found to improve lipid profiles and glucose metabolism, making it potentially beneficial for metabolic syndrome and diabetes management. Furthermore, its immunomodulatory properties can enhance the immune response, contributing to overall health.

Pharmacokinetics

The pharmacokinetics of emblica are not extensively studied; however, its active compounds are believed to be rapidly absorbed in the gastrointestinal tract. The bioavailability and half-life of these compounds can be influenced by factors such as formulation and concurrent food intake. Metabolism primarily occurs in the liver, and excretion is likely via both renal and biliary pathways.

Adverse effects

• Gastrointestinal upset
• Diarrhea
• Nausea
• Vomiting
• Allergic reactions

Interactions

• May interact with anticoagulants, enhancing their effects
• Possible antagonism with certain chemotherapy agents

Precautions

• Use with caution in individuals with allergies to plants in the Euphorbiaceae family
• Monitor blood sugar levels in diabetic patients

Pregnancy

Limited human data available; use only if clearly needed and benefits outweigh risks.

Breast-feeding

Limited data available; consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Powdered extract
• Capsules
• Tablets
• Liquid extract

Indications

• Anxiety
• Insomnia
• Nutritional supplement
• Antioxidant support
• Immune system support

Dosage

Children: Refer to authoritative sources for specific dosing information.

Adults: Refer to authoritative sources for specific dosing information.

Mechanism of action

The mechanism of action of Longan is not fully elucidated, but it is believed to exert its effects through the modulation of neurotransmitters, particularly influencing serotonin and gamma-aminobutyric acid (GABA) pathways. The fruit is rich in antioxidants, which may contribute to its protective effects against oxidative stress.

Pharmacodynamics

Longan is known for its high content of vitamins, minerals, and antioxidants, including vitamin C, B vitamins, and polyphenols. These compounds may enhance immune function, promote nervous system health, and improve skin health. Its calming effects may be attributed to constituents that influence neurotransmitter activity.

Pharmacokinetics

The pharmacokinetics of Longan is not well-studied, but as a food source, it is likely to be absorbed through the gastrointestinal tract. The bioavailability of its active compounds may vary depending on preparation methods (fresh, dried, or processed). The metabolism and excretion pathways are not clearly defined in the literature.

Pregnancy

Insufficient data on the safety of longa during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Insufficient data on the excretion of longa in human milk. Caution is advised when using during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Gastrointestinal disorders
• Diarrhea
• Dysentery
• Respiratory conditions
• Inflammatory conditions
• Antimicrobial therapy

Dosage

Children: Refer to herbal medicine guidelines or a qualified healthcare provider for appropriate dosing.

Adults: Refer to herbal medicine guidelines or a qualified healthcare provider for appropriate dosing.

Mechanism of action

The active constituents of marmelos, such as flavonoids and tannins, exhibit various pharmacological activities. These compounds are believed to exert anti-inflammatory effects by inhibiting pro-inflammatory mediators and enhancing antioxidant defense mechanisms. Additionally, marmelos may promote digestive health by stimulating gastric secretions and exhibiting antimicrobial properties against gastrointestinal pathogens.

Pharmacodynamics

Marmelos has been shown to modulate various biochemical pathways, including the inhibition of cyclooxygenase enzymes, leading to reduced prostaglandin synthesis and inflammation. Its antioxidant properties help combat oxidative stress, which is implicated in chronic diseases. Furthermore, the antimicrobial activity of marmelos may aid in protecting against infections, particularly in the gastrointestinal tract.

Pharmacokinetics

The pharmacokinetics of marmelos have not been extensively studied in clinical settings. However, it is known that the bioactive compounds are absorbed in the gastrointestinal tract, where they exert their effects. The metabolism and excretion pathways are not well defined, necessitating further research to clarify these aspects.

Pregnancy

There is insufficient reliable information regarding the safety of marmelos during pregnancy. It is advisable to consult a healthcare professional before use.

Breast-feeding

Due to limited data on the excretion of marmelos in breast milk, caution is recommended. It is best to consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Anxiety
• Sleep disorders
• Stress relief
• Mild depression
• Digestive issues

Dosage

Children: Dosage for paediatric patients should be determined by a qualified healthcare provider familiar

Adults: Dosage varies widely depending on the specific officinalis species and preparation. General guidance for herbal preparations should be followed, and consulting a healthcare professional is recommended.

Mechanism of action

The mechanism of action of officinalis species varies depending on the specific plant. For example, Melissa officinalis is thought to exert its effects primarily through modulation of GABA (gamma-aminobutyric acid) receptors, which are crucial for inhibitory neurotransmission in the brain. This interaction can lead to a calming effect, reducing anxiety and promoting sleep. Valeriana officinalis is believed to enhance GABAergic activity, potentially increasing GABA concentrations in the synaptic cleft, further contributing to its sedative properties.

Pharmacodynamics

Pharmacodynamics of officinalis species involve their effects on the central nervous system. The herbs are known to promote relaxation, reduce anxiety, and improve sleep quality. Their bioactive compounds, such as flavonoids and essential oils, are thought to influence neurotransmitter systems, particularly GABA, which plays a key role in anxiety regulation. Additionally, these plants may exhibit antioxidant properties, contributing to overall health benefits.

Pharmacokinetics

Pharmacokinetics of officinalis species can vary widely based on the specific plant and its preparation. Generally, the active components are absorbed in the gastrointestinal tract after ingestion. The onset of action can occur within 30 minutes to several hours, depending on the formulation. Metabolism occurs primarily in the liver, with elimination through urine. The half-life of the active compounds may vary, necessitating multiple doses for sustained effects.

Pregnancy

Consult healthcare provider before use. Limited data on safety in pregnancy.

Breast-feeding

Consult healthcare provider before use. Limited data on safety while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for proper dosing.

Adults: Refer to specific product guidelines or consult a healthcare professional for proper dosing.

Mechanism of action

The mechanism of action for reticulata, depending on the specific compound derived from it, could involve modulation of inflammatory pathways, inhibition of bacterial growth, or interaction with neurotransmitter systems. Specific studies are necessary to elucidate the exact pathways and targets of the active ingredients.

Pharmacodynamics

Pharmacodynamics of compounds from reticulata may vary, but generally may include dose-dependent effects on inflammation and pain relief. Potential interactions with various receptors or enzymes can influence the overall pharmacological effects observed.

Pharmacokinetics

Pharmacokinetics of plant-derived compounds is often complex, involving absorption, distribution, metabolism, and excretion that can be influenced by the preparation method and the individual's metabolic profile. Generally, active compounds may exhibit variable bioavailability and half-lives, necessitating careful consideration in dosing.

Pregnancy

Safety during pregnancy has not been established; use only if clearly needed.

Breast-feeding

Safety during breastfeeding has not been established; use caution.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Type 2 diabetes mellitus
• Impaired glucose tolerance
• Weight management
• Dyslipidemia

Dosage

Children: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to specific product guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The primary mechanism of action for Salacia involves the inhibition of enzymes such as alpha-glucosidase and pancreatic alpha-amylase. By inhibiting these enzymes, Salacia reduces the breakdown of carbohydrates into glucose, thereby decreasing postprandial blood glucose levels. Additionally, it may enhance insulin sensitivity and modulate glucose transporters, contributing to improved glycemic control.

Pharmacodynamics

Salacia exhibits pharmacodynamic properties that include the modulation of glucose metabolism and insulin sensitivity. Its active components, such as salacinol and kotalanol, have been shown to exert significant effects on carbohydrate metabolism, leading to decreased absorption of sugars in the intestine and improved overall glycemic status. Furthermore, Salacia may also support weight management through its effects on fat metabolism and appetite regulation.

Pharmacokinetics

The pharmacokinetic profile of Salacia is not extensively studied; however, its active compounds are believed to be absorbed in the gastrointestinal tract and subsequently metabolized in the liver. The elimination half-life and specific metabolic pathways have yet to be clearly defined. Given its natural origin, variability in bioavailability may occur based on individual metabolism and other factors.

Adverse effects

• Gastrointestinal discomfort
• Diarrhea
• Nausea
• Vomiting
• Hypoglycemia

Interactions

• May interact with antidiabetic medications, potentially enhancing their effects
• Possible interactions with other herbal supplements

Precautions

• Use with caution in patients with diabetes due to potential hypoglycemic effects
• Monitor blood glucose levels regularly if used alongside antidiabetic drugs
• Consult healthcare provider before use in individuals with underlying health conditions or those taking other medications

Pregnancy

Limited data is available on safety during pregnancy, consult a healthcare provider before use.

Breast-feeding

Insufficient data on excretion in breast milk; consult a healthcare provider before use.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Powder
• Capsule
• Tablet

Mechanism of action

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2. Curcumin, a polyphenolic natural product, exhibits therapeutic activity against a number of diseases, attributed mainly to its chemical structure and unique physical, chemical, and biological properties. It is a diferuloyl methane molecule [1,7-bis (4-hydroxy-3- methoxyphenyl)-1,6-heptadiene-3,5-dione)] containing two ferulic acid residues joined by a methylene bridge. It has three important functionalities: an aromatic o-methoxy phenolic group, alpha, beta-unsaturated beta-diketo moiety and a seven carbon linker. Extensive research in the last two decades has provided evidence for the role of these different functional groups in its crucial biological activities. A few highlights of chemical structural features associated with the biological activity of curcumin are: The o-methoxyphenol group and methylenic hydrogen are responsible for the antioxidant activity of curcumin, and curcumin donates an electron/ hydrogen atom to reactive oxygen species. Curcumin interacts with a number of biomolecules through non-covalent and covalent binding. The hydrogen bonding and hydrophobicity of curcumin, arising from the aromatic and tautomeric structures along with the flexibility of the linker group are responsible for the non-covalent interactions. The alpha, beta-unsaturated beta-diketone moiety covalently interacts with protein thiols, through Michael reaction. The beta-diketo group forms chelates with transition metals, thereby reducing the metal induced toxicity and some of the metal complexes exhibit improved antioxidant activity as enzyme mimics. New analogues with improved activity are being developed with modifications on specific functional groups of curcumin... The present study demonstrates that curcumin acts as pro-oxidant and sensitizes human lung adenocarcinoma epithelial cells (A549) to apoptosis via intracellular redox status mediated pathway. Results indicated that curcumin induced cell toxicity (light microscopy and MTT assay) and apoptosis (AnnexinV-FITC/PI labeling and caspase-3 activity) in these cells. These events seem to be mediated through generation of reactive oxygen species (ROS) and superoxide radicals (SOR) and enhanced levels of lipid peroxidation. These changes were accompanied by increase in oxidized glutathione (GSSG), reduced glutathione (GSH) and gamma-glutamylcysteine synthetase (gamma-GCS) activity, but decrease in GSH/GSSG ratio. The induction of apoptosis and decrease in GSH/GSSG ratio was also accompanied by sustained phosphorylation and activation of p38 mitogen activated protein kinase (MAPK). On the other hand, addition of N-acetyl cysteine (NAC), an antioxidant, blocked the curcumin-induced ROS production and rescued malignant cells from curcumin-induced apoptosis through caspase-3 deactivation. However, L-buthionine sulfoximine (BSO), a GSH synthesis blocking agent, further enhanced curcumin-induced ROS production and apoptosis in A549 cells. Decreased GSH/GSSG ratio seems to be a crucial factor for the activation of MAPK signaling cascade by curcumin. The study therefore, provides an insight into the molecular mechanism involved in sensitization of lung adenocarcinoma cells to apoptosis by curcumin. Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activiti

Pharmacodynamics

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.